Loading…
Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity
Monoclonal gammopathy of renal significance (MGRS) is a new nosological group of entities (meta-entity) defined in 2012, whose pathogenesis depends on monoclonal immunoglobulins (Ig) secreted by low-grade lymphoproliferative disorders, which belong to M-protein-related diseases. Renal damage is the...
Saved in:
Published in: | International urology and nephrology 2017-12, Vol.49 (12), p.2171-2175 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c372t-2c8018bf491d3c23490c96ba65869275c9e283b1898f18404ae36f8ce1e806dc3 |
---|---|
cites | cdi_FETCH-LOGICAL-c372t-2c8018bf491d3c23490c96ba65869275c9e283b1898f18404ae36f8ce1e806dc3 |
container_end_page | 2175 |
container_issue | 12 |
container_start_page | 2171 |
container_title | International urology and nephrology |
container_volume | 49 |
creator | Ciocchini, Mariana Arbelbide, Jorge Musso, Carlos G. |
description | Monoclonal gammopathy of renal significance (MGRS) is a new nosological group of entities (meta-entity) defined in 2012, whose pathogenesis depends on monoclonal immunoglobulins (Ig) secreted by low-grade lymphoproliferative disorders, which belong to M-protein-related diseases. Renal damage is the result of monoclonal Ig deposit or its activity as autoantibodies, which can compromise any nephronal area. MGRS does not include kidney diseases produced by high-grade lymphoproliferative disorders as well as those whose pathogenesis are independent of monoclonal Ig (such as drug toxicity or metabolic disorders). The importance of this hemato-nephrological meta-entity is based on two aspects: First, it is associated with increased morbidity and mortality, including recurrence in post-renal transplant or its appearance as “de novo” after it; and second, it usually improves after treating the plasmocyte or lymphocyte clone responsible, leading to the elimination of M-protein. Between low-grade lymphoproliferative disorders, monoclonal gammopathy of undetermined significance (MGUS) requires special consideration for two reasons: First, it is the disorder most related to MGRS; second, when MGUS progresses to MGRS, effective treatment against toxic underline clone should be performed taking into account the nephrological perspective. |
doi_str_mv | 10.1007/s11255-017-1594-y |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1959137735</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1959137735</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-2c8018bf491d3c23490c96ba65869275c9e283b1898f18404ae36f8ce1e806dc3</originalsourceid><addsrcrecordid>eNp1kE1LAzEQhoMoWj9-gBcJeNFDdCbZ7CbeRLQKFsGPc0jTbLvS3a1Jiuy_d0ur6MHTwMwz7zAPIccIFwhQXEZELiUDLBhKnbFuiwxQFoJxqbJtMgAByDDnYo_sx_gOAFoB7JI9rjIuocgHpB61TevmbWPndGrrul3YNOtoW9LgV71YTZuqrJxtnKdno-Hzy_kVTTNP3cwG65IPVUyVi9Q2k79wH2Fp4z9p7ZNlvklV6g7JTmnn0R9t6gF5u7t9vblnj0_Dh5vrR-ZEwRPjTgGqcZlpnAjHRabB6Xxsc6lyzQvptOdKjFFpVaLKILNe5KVyHr2CfOLEATld5y5C-7H0MZn3dhn6f6JBLTWKohCyp3BNudDGGHxpFqGqbegMglkJNmvBphdsVoJN1--cbJKX49pPfja-jfYAXwOxHzVTH36d_jf1C231hho</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1959137735</pqid></control><display><type>article</type><title>Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity</title><source>Springer Nature</source><creator>Ciocchini, Mariana ; Arbelbide, Jorge ; Musso, Carlos G.</creator><creatorcontrib>Ciocchini, Mariana ; Arbelbide, Jorge ; Musso, Carlos G.</creatorcontrib><description>Monoclonal gammopathy of renal significance (MGRS) is a new nosological group of entities (meta-entity) defined in 2012, whose pathogenesis depends on monoclonal immunoglobulins (Ig) secreted by low-grade lymphoproliferative disorders, which belong to M-protein-related diseases. Renal damage is the result of monoclonal Ig deposit or its activity as autoantibodies, which can compromise any nephronal area. MGRS does not include kidney diseases produced by high-grade lymphoproliferative disorders as well as those whose pathogenesis are independent of monoclonal Ig (such as drug toxicity or metabolic disorders). The importance of this hemato-nephrological meta-entity is based on two aspects: First, it is associated with increased morbidity and mortality, including recurrence in post-renal transplant or its appearance as “de novo” after it; and second, it usually improves after treating the plasmocyte or lymphocyte clone responsible, leading to the elimination of M-protein. Between low-grade lymphoproliferative disorders, monoclonal gammopathy of undetermined significance (MGUS) requires special consideration for two reasons: First, it is the disorder most related to MGRS; second, when MGUS progresses to MGRS, effective treatment against toxic underline clone should be performed taking into account the nephrological perspective.</description><identifier>ISSN: 0301-1623</identifier><identifier>EISSN: 1573-2584</identifier><identifier>DOI: 10.1007/s11255-017-1594-y</identifier><identifier>PMID: 28425076</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Autoantibodies ; Benign monoclonal gammopathy ; Humans ; Immunoglobulin Light Chains - blood ; Immunoglobulins ; Immunoproliferative diseases ; Kidney Diseases - blood ; Kidney Diseases - etiology ; Kidney Diseases - pathology ; Kidney transplantation ; Lymphocytes ; Medicine ; Medicine & Public Health ; Metabolic disorders ; Monoclonal antibodies ; Monoclonal Gammopathy of Undetermined Significance - blood ; Monoclonal Gammopathy of Undetermined Significance - complications ; Monoclonal Gammopathy of Undetermined Significance - pathology ; Morbidity ; Nephrology ; Nephrology – Review ; Pathogenesis ; Toxicity ; Urology</subject><ispartof>International urology and nephrology, 2017-12, Vol.49 (12), p.2171-2175</ispartof><rights>Springer Science+Business Media Dordrecht 2017</rights><rights>International Urology and Nephrology is a copyright of Springer, 2017.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-2c8018bf491d3c23490c96ba65869275c9e283b1898f18404ae36f8ce1e806dc3</citedby><cites>FETCH-LOGICAL-c372t-2c8018bf491d3c23490c96ba65869275c9e283b1898f18404ae36f8ce1e806dc3</cites><orcidid>0000-0002-8550-9564</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28425076$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ciocchini, Mariana</creatorcontrib><creatorcontrib>Arbelbide, Jorge</creatorcontrib><creatorcontrib>Musso, Carlos G.</creatorcontrib><title>Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity</title><title>International urology and nephrology</title><addtitle>Int Urol Nephrol</addtitle><addtitle>Int Urol Nephrol</addtitle><description>Monoclonal gammopathy of renal significance (MGRS) is a new nosological group of entities (meta-entity) defined in 2012, whose pathogenesis depends on monoclonal immunoglobulins (Ig) secreted by low-grade lymphoproliferative disorders, which belong to M-protein-related diseases. Renal damage is the result of monoclonal Ig deposit or its activity as autoantibodies, which can compromise any nephronal area. MGRS does not include kidney diseases produced by high-grade lymphoproliferative disorders as well as those whose pathogenesis are independent of monoclonal Ig (such as drug toxicity or metabolic disorders). The importance of this hemato-nephrological meta-entity is based on two aspects: First, it is associated with increased morbidity and mortality, including recurrence in post-renal transplant or its appearance as “de novo” after it; and second, it usually improves after treating the plasmocyte or lymphocyte clone responsible, leading to the elimination of M-protein. Between low-grade lymphoproliferative disorders, monoclonal gammopathy of undetermined significance (MGUS) requires special consideration for two reasons: First, it is the disorder most related to MGRS; second, when MGUS progresses to MGRS, effective treatment against toxic underline clone should be performed taking into account the nephrological perspective.</description><subject>Autoantibodies</subject><subject>Benign monoclonal gammopathy</subject><subject>Humans</subject><subject>Immunoglobulin Light Chains - blood</subject><subject>Immunoglobulins</subject><subject>Immunoproliferative diseases</subject><subject>Kidney Diseases - blood</subject><subject>Kidney Diseases - etiology</subject><subject>Kidney Diseases - pathology</subject><subject>Kidney transplantation</subject><subject>Lymphocytes</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Metabolic disorders</subject><subject>Monoclonal antibodies</subject><subject>Monoclonal Gammopathy of Undetermined Significance - blood</subject><subject>Monoclonal Gammopathy of Undetermined Significance - complications</subject><subject>Monoclonal Gammopathy of Undetermined Significance - pathology</subject><subject>Morbidity</subject><subject>Nephrology</subject><subject>Nephrology – Review</subject><subject>Pathogenesis</subject><subject>Toxicity</subject><subject>Urology</subject><issn>0301-1623</issn><issn>1573-2584</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNp1kE1LAzEQhoMoWj9-gBcJeNFDdCbZ7CbeRLQKFsGPc0jTbLvS3a1Jiuy_d0ur6MHTwMwz7zAPIccIFwhQXEZELiUDLBhKnbFuiwxQFoJxqbJtMgAByDDnYo_sx_gOAFoB7JI9rjIuocgHpB61TevmbWPndGrrul3YNOtoW9LgV71YTZuqrJxtnKdno-Hzy_kVTTNP3cwG65IPVUyVi9Q2k79wH2Fp4z9p7ZNlvklV6g7JTmnn0R9t6gF5u7t9vblnj0_Dh5vrR-ZEwRPjTgGqcZlpnAjHRabB6Xxsc6lyzQvptOdKjFFpVaLKILNe5KVyHr2CfOLEATld5y5C-7H0MZn3dhn6f6JBLTWKohCyp3BNudDGGHxpFqGqbegMglkJNmvBphdsVoJN1--cbJKX49pPfja-jfYAXwOxHzVTH36d_jf1C231hho</recordid><startdate>20171201</startdate><enddate>20171201</enddate><creator>Ciocchini, Mariana</creator><creator>Arbelbide, Jorge</creator><creator>Musso, Carlos G.</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><orcidid>https://orcid.org/0000-0002-8550-9564</orcidid></search><sort><creationdate>20171201</creationdate><title>Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity</title><author>Ciocchini, Mariana ; Arbelbide, Jorge ; Musso, Carlos G.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-2c8018bf491d3c23490c96ba65869275c9e283b1898f18404ae36f8ce1e806dc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Autoantibodies</topic><topic>Benign monoclonal gammopathy</topic><topic>Humans</topic><topic>Immunoglobulin Light Chains - blood</topic><topic>Immunoglobulins</topic><topic>Immunoproliferative diseases</topic><topic>Kidney Diseases - blood</topic><topic>Kidney Diseases - etiology</topic><topic>Kidney Diseases - pathology</topic><topic>Kidney transplantation</topic><topic>Lymphocytes</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Metabolic disorders</topic><topic>Monoclonal antibodies</topic><topic>Monoclonal Gammopathy of Undetermined Significance - blood</topic><topic>Monoclonal Gammopathy of Undetermined Significance - complications</topic><topic>Monoclonal Gammopathy of Undetermined Significance - pathology</topic><topic>Morbidity</topic><topic>Nephrology</topic><topic>Nephrology – Review</topic><topic>Pathogenesis</topic><topic>Toxicity</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ciocchini, Mariana</creatorcontrib><creatorcontrib>Arbelbide, Jorge</creatorcontrib><creatorcontrib>Musso, Carlos G.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>International urology and nephrology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ciocchini, Mariana</au><au>Arbelbide, Jorge</au><au>Musso, Carlos G.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity</atitle><jtitle>International urology and nephrology</jtitle><stitle>Int Urol Nephrol</stitle><addtitle>Int Urol Nephrol</addtitle><date>2017-12-01</date><risdate>2017</risdate><volume>49</volume><issue>12</issue><spage>2171</spage><epage>2175</epage><pages>2171-2175</pages><issn>0301-1623</issn><eissn>1573-2584</eissn><abstract>Monoclonal gammopathy of renal significance (MGRS) is a new nosological group of entities (meta-entity) defined in 2012, whose pathogenesis depends on monoclonal immunoglobulins (Ig) secreted by low-grade lymphoproliferative disorders, which belong to M-protein-related diseases. Renal damage is the result of monoclonal Ig deposit or its activity as autoantibodies, which can compromise any nephronal area. MGRS does not include kidney diseases produced by high-grade lymphoproliferative disorders as well as those whose pathogenesis are independent of monoclonal Ig (such as drug toxicity or metabolic disorders). The importance of this hemato-nephrological meta-entity is based on two aspects: First, it is associated with increased morbidity and mortality, including recurrence in post-renal transplant or its appearance as “de novo” after it; and second, it usually improves after treating the plasmocyte or lymphocyte clone responsible, leading to the elimination of M-protein. Between low-grade lymphoproliferative disorders, monoclonal gammopathy of undetermined significance (MGUS) requires special consideration for two reasons: First, it is the disorder most related to MGRS; second, when MGUS progresses to MGRS, effective treatment against toxic underline clone should be performed taking into account the nephrological perspective.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><pmid>28425076</pmid><doi>10.1007/s11255-017-1594-y</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0002-8550-9564</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0301-1623 |
ispartof | International urology and nephrology, 2017-12, Vol.49 (12), p.2171-2175 |
issn | 0301-1623 1573-2584 |
language | eng |
recordid | cdi_proquest_journals_1959137735 |
source | Springer Nature |
subjects | Autoantibodies Benign monoclonal gammopathy Humans Immunoglobulin Light Chains - blood Immunoglobulins Immunoproliferative diseases Kidney Diseases - blood Kidney Diseases - etiology Kidney Diseases - pathology Kidney transplantation Lymphocytes Medicine Medicine & Public Health Metabolic disorders Monoclonal antibodies Monoclonal Gammopathy of Undetermined Significance - blood Monoclonal Gammopathy of Undetermined Significance - complications Monoclonal Gammopathy of Undetermined Significance - pathology Morbidity Nephrology Nephrology – Review Pathogenesis Toxicity Urology |
title | Monoclonal gammopathy of renal significance (MGRS): the characteristics and significance of a new meta-entity |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T20%3A24%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Monoclonal%20gammopathy%20of%20renal%20significance%20(MGRS):%20the%20characteristics%20and%20significance%20of%20a%20new%20meta-entity&rft.jtitle=International%20urology%20and%20nephrology&rft.au=Ciocchini,%20Mariana&rft.date=2017-12-01&rft.volume=49&rft.issue=12&rft.spage=2171&rft.epage=2175&rft.pages=2171-2175&rft.issn=0301-1623&rft.eissn=1573-2584&rft_id=info:doi/10.1007/s11255-017-1594-y&rft_dat=%3Cproquest_cross%3E1959137735%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c372t-2c8018bf491d3c23490c96ba65869275c9e283b1898f18404ae36f8ce1e806dc3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1959137735&rft_id=info:pmid/28425076&rfr_iscdi=true |